|
2025
|
Invention
|
Per-operative treatment of post-operative complications (poc). The invention relates to the field... |
|
2024
|
Invention
|
Peptide modulators of the interaction between human c-peptide and human elastin receptor for ther... |
|
2023
|
Invention
|
Treating conditions with hypoglycemia associated with hyperinsulinemia.
The disclosure relates t... |
|
|
Invention
|
Treating conditions with hypoglycemia associated with hyperinsulinemia.. The disclosure relates t... |
|
|
Invention
|
Treating conditions with hypoglycemia associated with hyperinsulinemia. |
|
2022
|
Invention
|
Angiogenic control, preferably combined with glycaemic control.
The invention relates to a disti... |
|
|
Invention
|
Angiogenic control, preferably combined with glycaemic control.. The invention relates to a disti... |
|
|
Invention
|
Chemotactic autophagy-inhibiting peptide, compositions and methods related thereto.
Methods for ... |
|
|
Invention
|
Chemotactic autophagy-inhibiting peptide, compositions and methods related thereto.. Abstract The... |
|
2021
|
Invention
|
Autophagy-inhibiting peptide and organic acid salt thereof addressing issues of vascular permeabi... |
|
|
Invention
|
Methods and means for modifying hemodynamics in infections.
Provided is a method of treatment co... |
|
|
Invention
|
Methods and means for modifying hemodynamics in infections. Provided is a method of treatment com... |
|
2020
|
Invention
|
Q-er peptide.
Means and methods for treating diseases involving autophagy by cells, which is inv... |
|
|
Invention
|
Peptides for targeting autophagy inhibiting amino acids. The invention relates to means and metho... |
|
|
Invention
|
Q-er peptide. The invention relates to means and methods for the treatment of diseases involving ... |
|
2012
|
Invention
|
Modulators of prr and gpcr signalling. The invention relates to methods for determining whether a... |
|
2011
|
Invention
|
Immunoregulatory compositions.
wherein AAL is a substituted or unsubstituted non-polar amino aci... |
|
|
Invention
|
Compositions capable of reducing elevated blood urea concentration. The invention includes a meth... |
|
|
Invention
|
Immunoregulator. The invention relates to the field of immunology, more specifically to the field... |
|
2010
|
Invention
|
Control of radiation injury.
The invention relates to the field of drug development against acut... |
|
|
Invention
|
Treatment of burns.
The invention relates to the treatment of burn injuries. Described are metho... |
|
2009
|
Invention
|
Control of radiation injury. Methods of treating radiation injury of a subject in need thereof co... |
|
|
Invention
|
Gene regulator.
The invention relates to the modulation of gene expression in a cell, also calle... |
|
|
Invention
|
Methods for identifying biologically active peptides and predicting their function.
The inventio... |
|
|
Invention
|
Methods for identifying biologically active peptides and predicting their function. The invention... |
|
|
Invention
|
Methods and uses for protein breakdown products.
Where it was generally thought that the smalles... |
|
|
Invention
|
Compositions for mucosal and oral administration comprising hcg fragments.
The invention relates... |
|
2008
|
Invention
|
Inhibition of renal ischemia reperfusion injury by synthetic oligopeptides. The invention relates... |
|
|
Invention
|
Oligopeptide treatment of ischemia reperfusion injury.
The invention relates to the modulation o... |
|
|
Invention
|
Treatment of trauma-hemorrhage with short oligopeptides.
Described are methods and associated me... |
|
|
Invention
|
Treatment of trauma-hemorrhage with short oligopeptides. Described are methods and associate mean... |
|
|
Invention
|
Treatment of trauma hemorrhage with short oligopeptides. Described are methods and associate mean... |
|
|
Invention
|
Immunoregulatory compositions.
The invention relates to compounds exhibiting immunoregulatory ac... |
|
2007
|
Invention
|
Treatment of neurological disorders.
The description relates to the treatment of the inflammator... |
|
|
Invention
|
Stratification.
Provided is the use of a gene-regulatory peptide or functional analogue thereof ... |
|
|
Invention
|
Peptide compositions.
Described are treatments of disease wherein a gene-regulatory peptide as p... |
|
|
Invention
|
Treatment of iatrogenic disease.
The invention relates to the field of human or veterinary medic... |
|
|
Invention
|
Treatment of burns. The invention relates to the treatment of burn injuries. Described are method... |
|
2006
|
Invention
|
Compounds of therapeutic value in the treatment of multiple sclerosis and other diseases wherein ... |
